Predilife SA
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer pred… Read more
Market Cap & Net Worth: Predilife SA (0GA)
Predilife SA (F:0GA) has a market capitalization of $30.71K (€29.92K) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #43222 globally and #6891 in its home market, demonstrating a -1.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Predilife SA's stock price €3.01 by its total outstanding shares 9940 (9.94K).
Predilife SA Market Cap History: 2026 to 2026
Predilife SA's market capitalization history from 2026 to 2026. Data shows growth from $30.71K to $30.71K (0.00% CAGR).
Predilife SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Predilife SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0GA by Market Capitalization
Companies near Predilife SA in the global market cap rankings as of March 19, 2026.
Key companies related to Predilife SA by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #93 globally with a market cap of $174.19 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #150 globally with a market cap of $120.45 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #468 globally with a market cap of $45.61 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #507 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #93 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.19 Billion | $464.69 |
| #150 | Danaher Corporation | NYSE:DHR | $120.45 Billion | $191.50 |
| #468 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.61 Billion | $577.12 |
| #507 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Predilife SA Historical Marketcap From 2026 to 2026
Between 2026 and today, Predilife SA's market cap moved from $30.71K to $ 30.71K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €30.71K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Predilife SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.71K USD |
| MoneyControl | $30.71K USD |
| MarketWatch | $30.71K USD |
| marketcap.company | $30.71K USD |
| Reuters | $30.71K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.